Sanofi And GSK Launch Trial For COVID-19 Protein-Based Vaccine

French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments against the...